SCHEMBL5248595

SCHEMBL5248595

O=C(NCc1ccc(C(F)(F)F)cc1)C1(N2CCNCC2)Cc2ccccc2C1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 1/20 0.47
CHRM3 P20309 2/20 0.45
NAMPT P43490 2/20 0.45
MC4R P32245 1/20 0.43
MMP8 P22894 1/20 0.42
MAPK14 Q16539 1/20 0.41
MTOR P42345 1/20 0.41
MAPK10 P53779 1/20 0.40
AKT2 P31751 1/20 0.40
KCNH2 Q12809 2/20 0.39
KIF11 P52732 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
NR3C2 P08235 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4832298 0.99 TACR1 (0.46) TACR1CHRM3NAMPTMC4RMMP8
SCHEMBL5247333 0.91 TACR1 (0.58) TACR1CHRM3MTOR
Hydrochloric Acid SCHEMBL4837314 0.90 TACR1 (0.57) TACR1CHRM3MTOR
SCHEMBL5246174 0.88 MMP8 (0.53) TACR1NAMPTMC4RMMP8
SCHEMBL5247733 0.88 TACR1 (0.52) TACR1NAMPTMTOR
SCHEMBL5246557 0.87 NPC1 (0.48) MMP8
Hydrochloric Acid SCHEMBL4834764 0.87 MMP8 (0.52) TACR1NAMPTMC4RMMP8
Hydrochloric Acid SCHEMBL4832631 0.87 TACR1 (0.51) TACR1NAMPTMTOR
Hydrochloric Acid SCHEMBL4830172 0.86 KMT2A (0.47) MMP8
SCHEMBL5245143 0.85 MMP8 (0.47) NAMPTMMP8MAPK10CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1707564-B1 Indanyl-piperazine derivatives, process for their preparation and pharmaceutical compositions containing them SERVIER LAB (FR) 2007-09-12 EP disclosed
EP-1707564-A2 Indanyl-piperazine derivatives, process for their preparation and pharmaceutical compositions containing them Les Laboratoires Servier (FR) 2006-10-04 EP disclosed